Arab J Urol. 2012 Jun;10(2):104-9. doi: 10.1016/j.aju.2012.02.001. Epub 2012 Mar 15.
Erectile dysfunction in Arab countries. Part II: Diagnosis and treatment.
Arab journal of urology
Ahmed I El-Sakka
Affiliations
Affiliations
- Department of Urology, Suez Canal University, Ismailia, Egypt.
PMID: 26558011
PMCID: PMC4442901 DOI: 10.1016/j.aju.2012.02.001
Abstract
OBJECTIVE: To review local published data on the diagnosis and treatment of erectile dysfunction (ED) in Arab countries.
METHODS: MEDLINE was searched for English-language articles published from 2000 to 2011, using the search terms 'Arab countries', 'sexual dysfunction', 'diagnosis' and 'treatment'.
RESULTS: In all, 86 articles were found to be relevant to this review; only a few had a high level of evidence and the remaining studies used an uncontrolled design. Several local studies were consistent with previous reports showing that a customised diagnostic pathway, with full consideration of the patient's goals, is adopted by most clinicians to treat ED. For an effective treatment, the evaluation methods should answer important questions about the aetiology and severity of ED, as well as the patient's and partner's goals and expectations. As ED is known to be associated with many common medical comorbidities and medications, careful questioning can yield information about peripheral vascular disease, coronary artery disease, diabetes, hypertension, dyslipidaemia, and tobacco and alcohol use. The presence of psychological, neurological or chronic debilitating diseases can direct further evaluation.
CONCLUSION: The methods used for the diagnosis and treatment of ED need more investigation, especially in Arab countries. Only a few studies addressed the results of different methods of investigating and treating ED among Arab men.
Keywords: Arab countries; DM, diabetes mellitus; Diagnosis; ED, erectile dysfunction; EECP, enhanced external counterpulsation; IHD, ischaemic heart disease; IIEF, International Index of Erectile Function; PDE-5, phosphodiesterase-5; PE, premature ejaculation; PGE1, prostaglandin E1; Sexual dysfunction; Treatment
References
- J Sex Med. 2008 Jun;5(6):1451-4 - PubMed
- J Sex Marital Ther. 1990 Fall;16(3):181-7 - PubMed
- Clin Drug Investig. 2007;27(5):339-46 - PubMed
- J Sex Med. 2007 May;4(3):771-9 - PubMed
- J Sex Med. 2007 Sep;4(5):1448-53 - PubMed
- J Int Med Res. 2011;39(2):558-68 - PubMed
- Urology. 1993 Oct;42(4):468-81 - PubMed
- Urology. 1995 Mar;45(3):498-502 - PubMed
- Urology. 2003 Sep;62(3):525-31 - PubMed
- J Urol. 2004 Dec;172(6 Pt 1):2335-9 - PubMed
- Int J Impot Res. 2004 Apr;16(2):175-80 - PubMed
- Int J Impot Res. 2003 Dec;15(6):426-9 - PubMed
- Expert Opin Investig Drugs. 2011 Oct;20(10):1305-9 - PubMed
- Curr Med Res Opin. 2008 Jul;24(7):1965-73 - PubMed
- J Sex Med. 2011 Jul;8(7):2106-11 - PubMed
- J Sex Med. 2009 Aug;6(8):2305-10 - PubMed
- Pak J Pharm Sci. 2008 Jul;21(3):275-81 - PubMed
- Can J Urol. 1995 Mar;2(Supp1):13-7 - PubMed
- J Urol. 1992 Mar;147(3):623-6 - PubMed
- Int J Clin Pract. 2006 Jul;60(7):812-9 - PubMed
- Int J Impot Res. 2003 Apr;15 Suppl 1:S25-9 - PubMed
- Urology. 2006 Sep;68(3):642-7 - PubMed
- Urology. 2004 Aug;64(2):346-50 - PubMed
- Int J Impot Res. 2009 Nov-Dec;21(6):362-5 - PubMed
- J Sex Med. 2007 May;4(3):797-808 - PubMed
- Scand J Urol Nephrol. 2004;38(6):511-6 - PubMed
- Int J Impot Res. 2005 Mar-Apr;17(2):191-5 - PubMed
- J Sex Med. 2005 Mar;2(2):235-40 - PubMed
- Eur Urol. 2004 Oct;46(4):503-9 - PubMed
- Andrologia. 2009 Oct;41(5):319-21 - PubMed
- Int J Impot Res. 2006 Mar-Apr;18(2):180-5 - PubMed
- J Sex Med. 2005 Jul;2(4):551-8 - PubMed
Publication Types